How much care is everyone actually getting, now that Covid-19 isn’t scaring so m...
Officials in the U.K. and Europe are ramping up their campaigns urging eligible ...
Even as the vaccine field has floundered, other sectors of HIV research have flo...
Soon after he joined UC Riverside in 2015, Maurizio Pellecchia, a professor of b...
In a rare moment for science’s top honor, this year's Nobel in medicine or physi...
Congress temporarily extended a few pandemic-preparedness programs when it fores...
Just two years after the WHO’s historic recommendation of the first malaria vacc...
Alphabet’s life sciences company Verily has scored its first CDC contract, a hig...
Medicare Advantage plans really didn’t ratchet up their premiums for 2024, despi...
A U.S. judge has struck down a Trump administration rule that allowed health ins...
Former FDA official Madris Kinard built a database to help patients, doctors, an...
Want to stay on top of the science and politics driving biotech today? Sign up t...
A federal judge allowed the new Medicare drug price negotiation program to proce...
The Centers for Disease Control and Prevention is proposing a new policy aimed a...
Syndax Pharmaceuticals’ treatment for a genetically defined form of advanced leu...
Mirum Pharmaceuticals reported that a recently acquired drug for cerebrotendinou...
